Fresh Equities
Raises
Research
About
Looking for more information?

Contact our responsive and friendly client services team any time.

CYNATA THERAPEUTICS LIMITED

INVESTOR PRESENTATION - CYNATA THERAPEUTICS LIMITED

ASX:CYP

CYNATA THERAPEUTICS LIMITED

Health Care

Cynata Therapeutics Limited (CYP) is an Australian clinical-stage stem cell and regenerative medicine company developing therapies based on its proprietary CymerusA stem cell technology platform. The company intends to commercialise the use of MSC therapies worldwide to address a wide range of medical issues.

Read more

Market Cap

93.70m

Price at Close

$0.8

4w avg. Volume

205.26k

4w avg. Turnover

$184.19k

Announcements
announcementt+2 movementdate
  • Annual Report to Shareholders

    Periodic Reports

  • -4.19%

    23 Oct 2020

-4.19%

23 Oct 2020
  • Letter to Shareholders, Notice of AGM & Proxy Form

    Notice Of Meeting

  • -4.19%

    23 Oct 2020

-4.19%

23 Oct 2020
  • Date of AGM & Closing Date for Director Nominations

    Notice Of Meeting

  • -2.53%

    06 Oct 2020

-2.53%

06 Oct 2020
  • Potential Utility of Cymerus MSCs in Heart Attack Model

    Progress Report · Market sensitive

  • -1.92%

    23 Sep 2020

-1.92%

23 Sep 2020
  • Cynata Clinical Trial Results Published in Nature Medicine

    Progress Report

  • +19.88%

    14 Sep 2020

+19.88%

14 Sep 2020
  • Appendix 3G

    Issued Capital

  • +19.88%

    14 Sep 2020

+19.88%

14 Sep 2020
  • Cymerus MSCs Effective in Preclinical Lung Disease Study

    Progress Report · Market sensitive

  • +4.07%

    06 Sep 2020

+4.07%

06 Sep 2020
  • Appendix 4G

    Periodic Reports

  • -5.91%

    25 Aug 2020

-5.91%

25 Aug 2020
  • Appendix 4E & Annual Report

    Periodic Reports · Market sensitive

  • -5.91%

    25 Aug 2020

-5.91%

25 Aug 2020
  • Patient Enrolment Opens in COVID-19 Clinical Trial

    Progress Report · Market sensitive

  • -7.98%

    23 Aug 2020

-7.98%

23 Aug 2020
Market Data

Current Price

$0.8

52WK HIGH

$1.35

52WK LOW

$0.58

1YR RETURN

-39.39%

1YR RETURN VS. SECTOR

-58.49%

90 DAY RETURN

+28.00%

ASX RANK

807

/2,015

SECTOR RANK

16

/47

SHARES OUTSTANDING

117.12m
ASX:CYP

CYNATA THERAPEUTICS LIMITED

Health Care

Cynata Therapeutics Limited (CYP) is an Australian clinical-stage stem cell and regenerative medicine company developing therapies based on its proprietary CymerusA stem cell technology platform. The company intends to commercialise the use of MSC therapies worldwide to address a wide range of medical issues.

Read more

Market Cap

93.70m

Price at Close

$0.8

4w avg. Volume

205.26k

4w avg. Turnover

$184.19k

ASX:CYP is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.